How should iron sucrose extravasation be managed?

Iron Sucrose Extravasation Management

Immediately stop the infusion, leave the cannula in place, aspirate as much extravasated solution as possible, apply dry cold compresses for 20 minutes 4 times daily for 1-2 days, elevate the limb, and provide analgesia as needed 1.

Immediate Management Steps

When iron sucrose extravasation occurs, follow this algorithmic approach:

Step 1: Stop and Secure

• Stop the infusion immediately upon recognition of extravasation
• Leave the cannula in place - do not remove it yet
• Switch IV line to hydration fluid to keep vein open 2

Step 2: Aspirate

• Gently aspirate as much extravasated solution as possible through the existing cannula 1
• Document the volume removed in patient records
• Avoid manual pressure over the extravasated area - this can worsen tissue damage 1

Step 3: Local Thermal Treatment

• Apply dry cold compresses (ice packs) to the affected area 1
• Apply for 20 minutes, 4 times daily for 1-2 days 1
• Avoid alcohol compresses 1
• Cold application aids vasoconstriction and theoretically limits drug dispersion 3

Step 4: Supportive Care

• Elevate the affected limb 1
• Administer analgesia as necessary 1
• Monitor the site closely for progression

Important Caveats and What NOT to Do

Do not use subcutaneous corticosteroids - retrospective data from chemotherapy extravasation shows that 46% of patients receiving intralesional corticoids required surgical debridement versus only 13% without corticoids, suggesting a deleterious effect 1. While this evidence comes from chemotherapy extravasation, the principle of avoiding corticosteroids applies broadly to extravasation management.

Do not apply compression immediately - However, emerging evidence suggests that compression applied post-infusion may actually reduce skin staining 4. This represents a nuanced consideration: avoid compression during acute management, but it may be beneficial later for cosmetic outcomes.

Understanding Iron Extravasation Complications

Iron sucrose extravasation causes persistent brown skin discoloration (cutaneous siderosis) due to iron deposition in tissues 5, 6. Key characteristics:

• Timing varies: Some patients develop immediate discoloration, others notice it days post-infusion 5
• Persistence: Pigmentation can last over 1 month in 37% of cases and over 6 months in 18% of cases 6
• No necrosis: Unlike chemotherapy vesicants, iron extravasation typically does not cause tissue necrosis 6
• Cosmetic impact: Particularly distressing for young women, creating significant aesthetic concerns 6

Documentation Requirements

Mandatory documentation for each extravasation incident 1:

1. Patient name and identification number
2. Date and time of extravasation
3. Drug extravasated (iron sucrose) and concentration
4. Signs and symptoms (including patient-reported)
5. Description of IV access site
6. Extravasation area and approximate volume
7. Management steps with timestamps

Photographic documentation is helpful for follow-up and decision-making 1.

Patient Counseling

Inform patients about:

• Delayed reactions: Skin discoloration may appear hours to days after infusion 2
• Persistence: Brown staining may be permanent or long-lasting 6
• Treatment efficacy: Despite extravasation, anemia treatment often remains effective 5
• Follow-up options: Laser therapy available if staining persists (see below)

Long-Term Management of Persistent Staining

If brown pigmentation persists beyond several months:

Q-switched Nd:YAG laser therapy at 532 nm wavelength is the most effective treatment option 7:

• Treatment parameters: 0.6-1.0 J/cm² fluence with 4 mm spot size
• Typically requires 4 sessions
• Can achieve complete resolution over time
• Minimal adverse effects

Alternative consideration: Compression therapy may reduce staining if applied post-extravasation 4, though this requires further validation.

Prevention Strategies

• Use careful infusion techniques with secure IV access
• Monitor infusion site continuously during administration
• Educate patients to report burning, tingling, or pain immediately 3
• Consider using central venous access for patients requiring repeated iron infusions
• Healthcare professionals should maintain familiarity with extravasation protocols 3

Clinical Context

Iron sucrose (Venofer) is a polynuclear iron(III)-hydroxide complex with molecular weight 34,000-60,000 daltons 8. Following IV administration, it dissociates into iron and sucrose, with iron binding to transferrin for delivery to erythroid precursor cells 8. The sucrose component is eliminated renally (75% in 24 hours), while approximately 5% of iron is eliminated in urine 8. This pharmacology explains why extravasated iron deposits locally in tissues, causing persistent pigmentation.